Clin Mol Hepatol.
2025 Jan;31(1):e78-e80. 10.3350/cmh.2024.0750.
Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- Affiliations
-
- 1Division of Life Sciences, Jeonbuk National University, Jeonju, Korea
- 2Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea
- 3Program in Biomedical Science & Engineering, Inha University, Incheon, Korea
- 4Research Center for Controlling Intercellular Communication (RCIC), College of Medicine, Inha University, Incheon, Korea
- KMID: 2563465
- DOI: http://doi.org/10.3350/cmh.2024.0750
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression
- Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
- Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
- UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
